Financial News
Articles published by Merus N.V.
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update
August 01, 2024
From Merus N.V.
Via GlobeNewswire
Tickers
MRUS
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
Merus Announces First Patient Dosed in LiGeR-HN2, a Phase 3 Trial Evaluating Petosemtamab in 2/3L r/m HNSCC
July 24, 2024
From Merus N.V.
Via GlobeNewswire
Tickers
MRUS
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting
May 23, 2024
From Merus N.V.
Via GlobeNewswire
Tickers
MRUS
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
May 08, 2024
From Merus N.V.
Via GlobeNewswire
Tickers
MRUS
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
Merus to Participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
April 03, 2024
From Merus N.V.
Via GlobeNewswire
Tickers
MRUS
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
Merus to Participate in a Fireside Chat at the Leerink Partners Global Biopharma Conference
March 04, 2024
From Merus N.V.
Via GlobeNewswire
Tickers
MRUS
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update
February 28, 2024
From Merus N.V.
Via GlobeNewswire
Tickers
MRUS
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
Merus to Participate in Upcoming Investor Conferences
January 31, 2024
From Merus N.V.
Via GlobeNewswire
Tickers
MRUS
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
Merus Presents Interim Data on MCLA-129 at ESMO Asia Congress 2023
December 02, 2023
From Merus N.V.
Via GlobeNewswire
Tickers
MRUS
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
Merus Announces Publication of Abstracts on MCLA-129 for Presentation at ESMO Asia Congress 2023
November 26, 2023
From Merus N.V.
Via GlobeNewswire
Tickers
MRUS
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
November 02, 2023
From Merus N.V.
Via GlobeNewswire
Tickers
MRUS
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
Merus to Participate in Upcoming Investor Conferences
November 01, 2023
From Merus N.V.
Via GlobeNewswire
Tickers
MRUS
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
Merus’ Zeno Interim Data Continues to Demonstrate Robust and Durable Responses in NRG1+ Cancer
October 23, 2023
From Merus N.V.
Via GlobeNewswire
Tickers
MRUS
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
Merus Announces Business Update Conference Call
October 15, 2023
From Merus N.V.
Via GlobeNewswire
Tickers
MRUS
![](https://ml.globenewswire.com/media/4a4a06e3-96f9-480f-8610-e954552b070b/small/merus-logo-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.